Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients
Clinical trial NCT03078582 · COMPLETED
Trial details
- NCT number
- NCT03078582
- Sponsor
- Ra Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-08
- Primary completion
- 2018-03-28
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.